Results

Total Results: 46 records

Showing results for "hypotensive episodes".

21. Antipsychotics-Adults Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_surveillance.pdf
    August 30, 2014 - dosage • Follow-up period • Treatment of a first episode versus treatment in the context of previous episodes … dosage; follow-up period; treatment of a first episode versus treatment in the context of previous episodes … dosage; follow-up period; treatment of a first episode versus treatment in the context of previous episodes … haloperidol should be considered as among the best of the available options for the treatment of manic episodes … dosage; follow-up period; treatment of a first episode versus treatment in the context of previous episodes

22. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - In the four studies that did report episodes of ARB) angioedema, this adverse event was observed only

23. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - These agents may be administered as primary therapy to control acute episodes of preterm labor or as … maintenance therapy to prevent subsequent episodes. … While several studies have examined these agents for the control of acute episodes of preterm labor, … surrounding the use of terbutaline and other tocolytics as maintenance therapy to prevent recurrent episodes

24. Refining Key Questions: Interactive Case Study Quiz
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - gradually expanded the scope of rFVIIa use in hemophilia: Hemophilia A or B with inhibitors for bleeding episodes … gradually expanded the scope of rFVIIa use in hemophilia: Hemophilia A or B with inhibitors for bleeding episodes … Chronic prophylactic use in hemophilia A and B in the absence of bleeding episodes or procedures.

25. Refining Key Questions: Interactive Case Study Quiz
    effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - gradually expanded the scope of rFVIIa use in hemophilia: Hemophilia A or B with inhibitors for bleeding episodes … gradually expanded the scope of rFVIIa use in hemophilia: Hemophilia A or B with inhibitors for bleeding episodes … Chronic prophylactic use in hemophilia A and B in the absence of bleeding episodes or procedures.

26. Use of Natriuretic Peptide Measurement in the Management of Heart Failure | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/heart-failure-natriuretic-peptide/research-protocol
    December 20, 2011 - Current Page Topic Timeline Jun. 28, 2011 Topic Initiated Dec. 20, 2011 Research Protocol Nov. 20, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Use of Natriuretic Peptide Measurement in the Management of Heart Failure Research Protocol Archived December 20, 2011 Download Main Document PDF 36…

27. Treatments for Adults with Schizophrenia: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - Examples include age (younger and older patients), first-episodes, and duration of disease.

28. Antipsychotics-Adults Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
    August 01, 2012 - • Treatment of a first episode versus treatment in the context of previous episodes (previous exposure … to disorder subtypes, comorbid drug or alcohol use, treatment resistance, and number of previous episodes

29. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: December 20, 2011 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Use of Natriuretic Peptide Measurement in the Management of Heart Failure I. Backgrou…

30. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - harms. 2 The impact of ACEI/ARB/DRI on development of non-angioedema adverse effects (such as hypotensive … In the four studies that did report episodes of angioedema, this adverse event was observed only in … The impact of ACEI/ARB/DRI on development of non-angioedema adverse effects (such as hypotensive symptoms … harms 2 The impact of ACEI/ARB/DRI on development of non-angioedema adverse effects (such as hypotensive … 296 pts 19 The impact of ACE-I/ARB/DRI on development of non-angioedema adverse effects (such as hypotensive

31. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - In the studies that did report episodes of angioedema, this adverse event was observed only in patients

32. Dietary-Supplements Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - than normal; renal insufficiency (serum creatinine>2, or clearance <60ml/min), recent bleeding episodes

33. Migraine-Emergency Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
    November 01, 2012 - 1 Comparative Effectiveness Review Number 84 Acute Migraine Treatment in Emergency Settings Executive Summary Introduction Migraine is a chronic neurovascular disorder characterized by dysfunction of the central and peripheral nervous systems and intracranial vasculature.1 Acute exacerbations of episodic …

34. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
    November 07, 2023 - Perhaps it would be better written as "number of heavy drinking episodes or number of drinking or heavy … Number of episodes or days doesn't seem equivalent to me as days with no drinking.

35. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - with high titer inhibitors who rely on bypassing agents, such as rFVIIa, to treat frequent bleeding episodes … The Report’s current statement that “most hemophilia patients never require rFVIIa for bleeding episodes … Since physicians have reported on and demonstrated the potential use of rFVIIa for treating bleeding episodes … hemophilia treatment center (HTC) focused approach to one in which the majority of patients and bleeding episodes

36. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
    October 01, 2016 - b “Coercion” refers to a sequence of coercive episodes (seclusion, mechanical restraint, or involuntary … Reduction of episodes of seclusion and restraint in a psychiatric emergency service. … Mechanical restraint--which interventions prevent episodes of mechanical restraint?

37. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - which autoantibodies produced against the body’s coagulation factors result in excessive bleeding episodes … fecal incontinence, in which primary endpoints included a 50% or more reduction in fecal incontinence episodes … which autoantibodies produced against the body’s coagulation factors result in excessive bleeding episodes … recombinant factors (i.e., not from plasma) of the missing factor, cryoprecipitate for acute bleeding episodes … OBI-1 is safe and effective for the treatment of serious bleeding episodes in individuals with acquired

38. Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
    November 01, 2011 - Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth Effective Health Care Program Number 35 Research Reports Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth William O. Cooper, M.…

39. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
    August 01, 2014 - For critically ill hypotensive patients with no clear focal bacterial infection and negative blood cultures … meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes … 2 6 G-2 Rank Research Questions Total Votesi Weighted Score 11 For critically ill hypotensive

40. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
    June 28, 2013 - Disposition of Comments Report for Treatment of Atrial Fibrillation Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Treatment of Atrial Fibrillation Draft review available for public comment from July 27, 2012 to August 24, 2012. Suggested citation: A…